Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,534.00p
   
  • Change Today:
    -40.00p
  • 52 Week High: 2,028.00
  • 52 Week Low: 1,191.00
  • Currency: UK Pounds
  • Shares Issued: 211.71m
  • Volume: 144,583
  • Market Cap: £3,247.66m
  • RiskGrade: 125
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 2,553.00 544.00 194.80¢ 15.2 1.2 +13% 54.00¢ 1.8%
31-Dec-22 2,517.00 233.00 181.00¢ 11.5 n/a -7% 56.00¢ 2.7%
31-Dec-23 2,875.00 281.00 223.00¢ 10.7 0.5 +23% 72.00¢ 3.0%
31-Dec-24 3,127.00 455.00 224.00¢ 11.9 n/a 0% 80.00¢ 3.0%
31-Dec-25 3,349.00 519.00 228.00¢ 9.1 4.5 +2% 84.00¢ 4.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 3,461.44 698.82 165.22p 9.5 n/a -3% 63.58p 0.0%
31-Dec-27 3,614.63 746.77 182.01p 8.6 0.8 +10% 67.24p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 15.41 9.16 11.26 0.79

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

HIK Market Data

Currency UK Pounds
Share Price 1,534.00p
Change Today -40.00p
% Change -2.54 %
52 Week High 2,028.00
52 Week Low 1,191.00
Volume 144,583
Shares Issued 211.71m
Market Cap £3,247.66m
Beta 0.00
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average
13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average
Income
38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 19-Mar-26 14-Aug-25
Paid 30-Apr-26 18-Sep-25
Amount 48.00¢ 36.00¢

Trades for 14-Jul-2026

Time Volume / Share Price
11:00 218 @ 1,535.00p
11:00 20 @ 1,534.00p
11:00 245 @ 1,534.00p
10:57 221 @ 1,534.00p
10:56 191 @ 1,534.00p

HIK Key Personnel

CEO Said Darwazah
Chair Victoria Hull

Top of Page